erythromycin has been researched along with Acinetobacter Infections in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Adams, FG; Eijkelkamp, BA; Hassan, KA; Zang, M | 1 |
Akeda, Y; Arakawa, Y; Miyamoto, K; Onda, M; Shoji, M; Terada, K; Tomono, K; Tsuchiya, T; Yamabe, K | 1 |
Bercault, N; Linassier, P | 1 |
Kassen, J; Lerner, P | 1 |
Chiemchanya, S; Visudhiphan, P | 1 |
Spitzy, KH | 1 |
1 review(s) available for erythromycin and Acinetobacter Infections
Article | Year |
---|---|
[Ecological viewpoints in antibacterial chemotherapy].
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Antifungal Agents; Clostridium Infections; Corynebacterium; Drug Synergism; Enteritis; Erythromycin; Escherichia coli Infections; Female; Humans; Infections; Mycobacterium Infections; Mycoses; Neomycin; Penicillins; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Vaginitis | 1970 |
5 other study(ies) available for erythromycin and Acinetobacter Infections
Article | Year |
---|---|
The Impact of Omega-3 Fatty Acids on the Evolution of Acinetobacter baumannii Drug Resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Arachidonic Acid; Cell Membrane; Docosahexaenoic Acids; Drug Resistance, Multiple, Bacterial; Erythromycin; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Mutation Rate; Selection, Genetic; Tetracyclines; Whole Genome Sequencing | 2021 |
Direct anti-biofilm effects of macrolides on Acinetobacter baumannii: comprehensive and comparative demonstration by a simple assay using microtiter plate combined with peg-lid.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyl-Butyrolactones; Agrobacterium tumefaciens; Anti-Bacterial Agents; Azithromycin; Biofilms; Biological Assay; Clarithromycin; Erythromycin; Fidaxomicin; Humans; Ivermectin; Josamycin; Microbial Sensitivity Tests; Microbial Viability; Quorum Sensing; Spiramycin | 2020 |
[The value of sepsis isolation to diminish the spread of multidrug-resistant bacteria in intensive care. Consequences on the incidence of nosocomial infections].
Topics: Acinetobacter Infections; Adult; Anti-Bacterial Agents; Colistin; Critical Care; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Patient Isolation; Risk Factors | 1999 |
Legionnaires' disease and acinetobacter bacteremia.
Topics: Acinetobacter Infections; Aged; Erythromycin; Female; Humans; Legionnaires' Disease; Sepsis | 1979 |
Mima polymorpha ventriculitis in a young infant. Problems in overcoming the infection with erythromycin intraventricularly.
Topics: Acinetobacter Infections; Brain Diseases; Cerebral Ventricles; Erythromycin; Female; Humans; Infant, Newborn; Injections, Intraventricular | 1975 |